Navigation Links
Impact of Open Source Software on Clinical Trials Grows With Release of OpenClinica 3.0 Electronic Data Capture Software

Latest release of popular clinical trials software adds new features, enhanced performance.

Waltham, MA (PRWEB) October 14, 2009 -- Akaza Research is pleased to announce the release of OpenClinica 3.0, the newest version of the world's most popular open source electronic data capture (EDC) software for clinical trials. This latest production release marks a significant milestone for open source software in the clinical trials field, adding a host of new capabilities designed to further accelerate the adoption of open source into mainstream research.

"OpenClinica 3.0 brings a new level of simplicity to EDC," said Cal Collins, CEO of Akaza Research. "We have added powerful new capabilities and made them accessible through an intelligent, task-oriented user interface. Each user can be confident that OpenClinica will make them more productive at their job."

Some of the enhancements in OpenClinica 3.0 include:

- Streamlined user interface that simplifies site usage
- Study progress dashboard
- Improved query workflows, with notifications, chain of custody, and task management
- Source data verification workspace
- Faster page load time
- Dedicated Study Build module
- Improved control over significant digits in eCRF data items
- Job scheduler
- Web services interface to allow for programmatic data interchange with other systems

"This release illustrates how an open source community can produce superior software," said Paul Galvin, OpenClinica Project Manager at Akaza Research. "Contributions and input from both industry and academic users and developers across the globe has allowed us to release the most feature rich, thoroughly tested, and high performance version of OpenClinica to-date."

As open source software, OpenClinica is free for organizations to use and modify. The software may be downloaded from with installation scripts as well as upgrade scripts for users utilizing the previous version of OpenClinica. A public demonstration instance is available at

OpenClinica Enterprise, the commercial distribution of OpenClinica, is available through Akaza Research. More information see

Webinar Presentation of OpenClinica 3.0

Akaza Research will be conducting a webinar presentation of OpenClinica 3.0 on October 28, 2009 to demonstrate the new product and answer questions form the community. Registration for this event is free.

Wednesday, October 28 @ 9:30 -11:00 Eastern Time U.S. (GMT -4:00) - Register Here
Wednesday, October 28 @ 18:00 - 19:30 Eastern Time U.S. (GMT -4:00) - Register Here

About OpenClinica®

OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical trial data management. OpenClinica facilitates data collection via electronic case report forms (eCRFs), and provides tools for data management and productive monitoring of clinical trials. OpenClinica supports CDISC standards and is designed to be compliant with industry and government regulations and guidelines such as 21 CFR Part 11, GCP, and HIPAA. OpenClinica is professionally supported by Akaza Research and has a worldwide open source community of over 7,500 users and developers. OpenClinica is freely available for download and use from

About Akaza Research®

Akaza Research provides professional open source software for clinical trials. The company's flagship product, OpenClinica, provides electronic data capture (EDC) and clinical data management (CDM) capabilities for clinical research. By bringing open source software into the mainstream of clinical research, Akaza is able to provide a cost effective technology solution that is more flexible and transparent than proprietary, closed systems. Akaza Research provides a full spectrum of OpenClinica-related products and services to a worldwide customer base through its OpenClinica EnterpriseTM solution. For more information about Akaza Research, see


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. New Survey Shows Devastating Impact of Rheumatoid Arthritis Pain on Intimate Relations
2. Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor
3. Plastics that convert light to electricity could have a big impact
4. Novel method predicts impact of a covert anthrax release
5. Novel method predicts impact of a covert anthrax release
6. OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427
7. World Micromachine Summit highlights technologies impacting energy and the environment
8. Event Alert: SPL R4 Compliance and its Impact on Regulatory Submission Processes
9. What Will Be the Impact of Programs of Study?
10. PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
11. Latest BioTrends Research Reports to Assess the Impact of the Withdrawal of Raptiva (efalizumab) on the Psoriasis Market
Post Your Comments:
Related Image:
Impact of Open Source Software on Clinical Trials Grows With Release of OpenClinica 3.0 Electronic Data Capture Software 
(Date:10/12/2017)... CA (PRWEB) , ... October ... ... ( ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed ... bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... announced today it will be hosting a Webinar titled, “Pathology is going digital. ... Associates , on digital pathology adoption best practices and how Proscia improves lab ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... Oct. 10, 2017 International research firm Parks Associates ... speak at the TMA 2017 Annual Meeting , October 11 in ... the residential home security market and how smart safety and security products ... Parks Associates: Smart ... "The residential security market ...
Breaking Biology Technology:
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):